Literature DB >> 25128070

Mesenchymal stem cells in lung cancer tumor microenvironment: their biological properties, influence on tumor growth and therapeutic implications.

Renwang Liu1, Sen Wei1, Jun Chen2, Song Xu3.   

Abstract

The tumor microenvironment (TME) of lung cancer has been documented to play an important role in participating in tumor disease progression. As the precursor of most stroma in TME, mesenchymal stem cells (MSCs) draw great attention since evidence has suggested that MSCs derived from lung cancer patients present a different phenotype compared to their normal counterparts. Furthermore, MSCs could be recruited towards tumor sites and influence tumor survival, although the effect remains contradictory. Our review will summarize the current advance of the role MSCs in lung cancer and explore the possible treatment strategies by blocking their crosstalk.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Lung cancer; Mesenchymal stem cells; Microenvironment

Mesh:

Year:  2014        PMID: 25128070     DOI: 10.1016/j.canlet.2014.07.047

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer.

Authors:  S Arena; M Salati; G Sorgentoni; F Barbisan; M Orciani
Journal:  Clin Transl Oncol       Date:  2018-05-23       Impact factor: 3.405

2.  Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.

Authors:  Oshrat Attar-Schneider; Victoria Zismanov; Liat Drucker; Maya Gottfried
Journal:  Tumour Biol       Date:  2015-10-30

Review 3.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

4.  The promising role and prognostic value of miR-198 in human diseases.

Authors:  Xiaoping Wang; Yanxia Zhu; Qiuli Xie
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

Review 5.  Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis.

Authors:  Sha Zhao; Tao Jiang; Limin Zhang; Hui Yang; Xiaozhen Liu; Yijun Jia; Caicun Zhou
Journal:  Oncotarget       Date:  2016-06-14

6.  Health state dependent multiphoton induced autofluorescence in human 3D in vitro lung cancer model.

Authors:  Vasyl Kilin; Christophe Mas; Samuel Constant; Jean-Pierre Wolf; Luigi Bonacina
Journal:  Sci Rep       Date:  2017-11-24       Impact factor: 4.379

7.  Notch signaling and non-small cell lung cancer.

Authors:  Bin Zou; Xue-Liang Zhou; Song-Qing Lai; Ji-Chun Liu
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

8.  Bone Marrow Derived Mesenchymal Stem Cells Involve in the Lymphangiogenesis of Lung Cancer and Jinfukang Inhibits the Involvement In Vivo.

Authors:  Xian-Mei Zhou; Dan Wang; Hai-Lang He; Jie Tang; Jing Wu; Ling Xu; Jian-Xin Li
Journal:  J Cancer       Date:  2017-07-01       Impact factor: 4.207

9.  Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis.

Authors:  Giulia Fregni; Mathieu Quinodoz; Emely Möller; Joanna Vuille; Sabine Galland; Carlo Fusco; Patricia Martin; Igor Letovanec; Paolo Provero; Carlo Rivolta; Nicolo Riggi; Ivan Stamenkovic
Journal:  EBioMedicine       Date:  2018-02-23       Impact factor: 8.143

Review 10.  Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression.

Authors:  Francesca Cammarota; Mikko O Laukkanen
Journal:  Stem Cells Int       Date:  2015-12-21       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.